CompletedNot Applicable

Cognitive Functioning in People With Myasthenia Graivs: Impact on Daily Life Activities, Work, Disability and Quality of Life

Italy150 participantsStarted 2023-06-07

Plain-language summary

MYCOG primarily aims to estimate the prevalence of cognitive difficulties in patients with MG treated at Besta Institute. Secondary aims include: a) assess the degree to which cognitive difficulties are associated to work impairment, limitations in ADL, symptoms of anxiety and depression, fatigue, disability and QoL; b) assess whether patients with different MG types show different degrees of cognitive impairment; c) assess whether patients with different MG antibody profiles show different degrees of cognitive impairment; d) assess whether patients under different MG-specific pharmacological treatments show different degrees of cognitive impairment.

Who can participate

Age range18 Years – 99 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients with MG, * followed-up at Besta institute * aged 18-99, * able to understand Italian language; Exclusion Criteria: * psychiatric comorbidies of psychotic nature; * do not accept to participate on a voluntary basis; * patients who should be excluded based on physician's judgement; * patients who live in a nursing home for aged or disabled persons; * respiratory impairment (patients under mechanical ventilation)

What they're measuring

GEMS

Timeframe: 22 months

Trial details

NCT IDNCT06718855

SponsorFondazione I.R.C.C.S. Istituto Neurologico Carlo Besta

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2025-08-12

View on ClinicalTrials.gov More Myasthenia Gravis trials